Jagran Josh Logo

Union Government launched HIV Salvage Therapy

Feb 13, 2014 17:20 IST

Union Ministry of Health and Family Welfare launched third-line drug therapy for people living with HIV/AIDS on 12 February 2014. The third-line therapy also called salvage or rescue therapy is prescribed for people who have limited drug options left.  

The announcement for the salvage therapy was made by Union Health Minister Ghulam Nabi Azad at the launch of at the launch of the National AIDS Control Programme Phase IV (2012-2017).

The highly expensive therapy will be provided free. The third-line therapy would enhance longevity and improve the quality of life of patients.

imageThe Union Health Ministry also extended free anti-retroviral therapy (ART) to more of them by revising the eligibility norm.

For receiving free ART, the minimum CD4-count limit had been reduced from 500 to 350. The count is a measure of the viral load.

Anti Retroviral Therapy

Anti Retroviral therapy (ART) consists of the combination of at least three antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression of HIV disease.

Huge reductions have been seen in rates of death and suffering when use is made of a potent ARV regimen, particularly in early stages of the disease.

Furthermore, expanded access to ART can also reduce the HIV transmission at population level, impact orphanhood and preserve families.

Is this article important for exams ? Yes46 People Agreed

DISCLAIMER: JPL and its affiliates shall have no liability for any views, thoughts and comments expressed on this article.

Latest Videos

Register to get FREE updates

    All Fields Mandatory
  • (Ex:9123456789)
  • Please Select Your Interest
  • Please specify

  • ajax-loader
  • A verifcation code has been sent to
    your mobile number

    Please enter the verification code below

Newsletter Signup
Follow us on
This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK